Advocate Physician Partners Accountable Care, Inc
Transparency is one important aspect of patient centeredness and patient engagement in the Medicare Shared Savings Program. We believe public reporting aids transparency and can promote more informed patient choice, provide feedback to stakeholders and providers, help improve quality and lower the cost of care, and improve oversight with respect to Advocate Physician Partners Accountable Care, Inc.'s (APPAC, Inc.) compliance with program requirements. This page provides important information for the public about APPAC, Inc.
Advocate Physician Partners Accountable Care, Inc.
1701 West Golf Road, Suite 2-1100
Rolling Meadows, IL 60008
ACO Primary contact
Dan Fisher
804-380-1174
daniel.fisher@aah.org
2025 Performance Year Participants
Key ACO Clinical and Administrative Leadership
Mike Barbati, ACO Executive
Amanpreet Sethi, MD, Medical Director
Melissa Pollock, Compliance Officer
Shital Tanna, MD, FAAFP, Quality Assurance/Improvement Officer
Associated Committees and Committee Leadership
Quality Improvement Committee, Shital Tanna, MD, FAAFP, Chair
Compliance Committee, Melissa Pollock, Chair
Finance Committee, Salvatore Vittore, Chair
Types of ACO participants, or combinations of participants, that formed the ACO:
- Partnerships or joint venture arrangements between hospitals and ACO professionals
Amount of Shared Savings/Losses
- Fourth Agreement Period
- Performance Year 2025, N/A
- Performance Year 2024, N/A
- Third Agreement Period
- Performance Year 2023, $37,097,941
- Performance Year 2022, $38,033,599
- Performance Year 2021, $27,884,292
- Performance Year 2020, $37,595,221
- Performance Year 2019, $22,748,457
- Second Agreement Period
- Performance Year 2018, $15,673,670
- Performance Year 2017, $0
- Performance Year 2016, $28,924,272
- First Agreement Period
- Performance Year 2015, $33,537,591
- Performance Year 2014, N/A
- Performance Year 2013, N/A
Note: Our ACO participated in multiple performance years during Calendar Year 2019. The shared savings/losses amount reported for Performance Year 2019 therefore represents net shared savings or losses across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.
Shared Savings Distributions- Fourth Agreement Period
- Performance Year 2025
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2024
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2025
- Third Agreement Period
- Performance Year 2023
- Proportion invested in infrastructure: 6%
- Proportion invested in redesigned care processes/resources: 56%
- Proportion of distribution to ACO participants: 38%
- Performance Year 2022
- Proportion invested in infrastructure: 1%
- Proportion invested in redesigned care processes/resources: 32%
- Proportion of distribution to ACO participants: 67%
- Performance Year 2021
- Proportion invested in infrastructure: 2%
- Proportion invested in redesigned care processes/resources: 27%
- Proportion of distribution to ACO participants: 71%
- Performance Year 2020
- Proportion invested in infrastructure: 1%
- Proportion invested in redesigned care processes/resources: 25%
- Proportion of distribution to ACO participants: 74%
- Performance Year 2019
- Proportion invested in infrastructure: 1%
- Proportion invested in redesigned care processes/resources: 30%
- Proportion of distribution to ACO participants: 69%
- Performance Year 2023
- Second Agreement Period
- Performance Year 2018
- Proportion invested in infrastructure: 1%
- Proportion invested in redesigned care process/resources: 32%
- Proportion of distribution to ACO participants: 67%
- Performance Year 2017
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2016
- Proportion invested in infrastructure: 2%
- Proportion invested in redesigned care processes/resources: 48%
- Proportion of distribution to ACO participants: 50%
- Performance Year 2018
- First Agreement Period
- Performance Year 2015
- Proportion invested in infrastructure: 5%
- Proportion invested in redesigned care processes/resources: 43%
- Proportion of distribution to ACO participants: 52%
- Performance Year 2014
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2013
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2012
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2015
Note: Our ACO participated in multiple performance years during Calendar Year 2019. The distribution of shared savings reported for Performance Year 2019 therefore represents the distribution of the net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019.
Quality Performance Results
2023 Quality Performance Reviews
Q uality performance results are based on the CMS Web Interface collection type.
Measure # | Measure Name | Collection Type | Rate | ACO Mean |
---|---|---|---|---|
001 | Diabetes: Hemoglobin A1c (HbA1c) Poor Control1 | CMS Web Interface | 8.25 | 9.84 |
134 | Preventative Care and Screening: Screening for Depression and Follow-up Plan | CMS Web Interface | 90.33 | 80.97 |
236 | Controlling High Blood Pressure | CMS Web Interface | 82.27 | 77.80 |
318 | Falls: Screening for Future Fall Risk | CMS Web Interface | 90.85 | 89.42 |
110 | Preventative Care and Screening: Influenza Immunization | CMS Web Interface | 81.96 | 70.76 |
226 | Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention | CMS Web Interface | 74.36 | 79.29 |
113 | Colorectal Cancer Screening | CMS Web Interface | 76.99 | 77.14 |
112 | Breast Cancer Screening | CMS Web Interface | 86.12 | 80.36 |
438 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | CMS Web Interface | 91.47 | 87.05 |
370 | Depression Remission at Twelve Months | CMS Web Interface | 1.89 | 16.58 |
321 | CAHPS for MIPS3 | CAHPS for MIPS Survey | 6.45 | 6.25 |
479 | Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups1 | Administrative Claims | 0.1624 | 0.1553 |
CAHPS-1 | Getting Timely Care, Appointments, and Information | CAHPS for MIPS Survey | 80.05 | 83.68 |
CAHPS-2 | How Well Providers Communicate | CAHPS for MIPS Survey | 94.82 | 93.69 |
CAHPS-3 | Patient’s Rating of Provider | CAHPS for MIPS Survey | 92.77 | 92.14 |
CAHPS-4 | Access to Specialists | CAHPS for MIPS Survey | 76.99 | 75.97 |
CAHPS-5 | Health Promotion and Education | CAHPS for MIPS Survey | 66.42 | 63.93 |
CAHPS-6 | Shared Decision Making | CAHPS for MIPS Survey | 58.81 | 61.60 |
CAHPS-7 | Health Status and Functional Status | CAHPS for MIPS Survey | 74.26 | 74.12 |
CAHPS-8 | Care Coordination | CAHPS for MIPS Survey | 85.51 | 85.77 |
CAHPS-9 | Courteous and Helpful Office Staff | CAHPS for MIPS Survey | 94.40 | 92.31 |
CAHPS-11 | Stewardship of Patient Resources | CAHPS for MIPS Survey | 24.28 | 26.69 |
For previous years’ financial and quality performance results, please visit data.cms.gov
Payment rule waivers
- Skilled Nursing Facility (SNF) 3-day rule waiver:
- Yes, our ACO does use the SNF 3-day rule waiver, pursuant to 42 CFR 425.612.
- Waiver for payment for telehealth services:
- Yes, our ACO clinicians do provide telehealth services using the flexibilities under 42 CFR 425.612(f) and 42 CFR 425.613.
- Fraud and Abuse Waivers:
- Yes, our ACO is using waivers of federal fraud and abuse laws as described in 80 FR 66725. The required disclosures can be accessed here.